Kura Oncology
Matt Kelly has over 10 years of experience in regulatory affairs, with a focus on the pharmaceutical and biotechnology industries. Matt is currently the Executive Director and Head of Regulatory Affairs at Kura Oncology, Inc., a position they have held since January 2023. Prior to their current role, Matt held various positions at Kura Oncology, including Senior Director and Director of Regulatory Affairs from 2020 to 2023. Before joining Kura Oncology, Matt worked at Sarepta Therapeutics as an Associate Director of Regulatory Strategy for Gene Therapy from 2018 to 2020. Matt also had a long tenure at Incyte, where they held the position of Senior Manager of Global Regulatory Affairs from 2010 to 2018. Overall, Matt Kelly brings a wealth of experience and expertise in regulatory affairs to their current role at Kura Oncology.
Matt Kelly holds a Bachelor of Arts (B.A.) degree from Lafayette College. Matt also has a Master of Science (M.S.) degree from The Johns Hopkins University.
This person is not in any offices
Kura Oncology
20 followers
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment.